Rnagene
Korea’s first developer of messenger RNA therapeutics.
"Laplace Partners excels at identifying and supporting promising biotech and IT startups with differentiated technologies, positioning them to lead innovation in the post-COVID era."
"Laplace Partners excels at identifying and supporting promising biotech and IT startups with differentiated technologies, positioning them to lead innovation in the post-COVID era."
"Laplace Partners excels at identifying and supporting promising biotech and IT startups with differentiated technologies, positioning them to lead innovation in the post-COVID era."